Lean Stack
Dual-agonist weight management with cellular energy underneath.
Dual GIP / GLP-1 agonist in a 40 mg click pen, studied for metabolic and weight research.
High-dose NAD+ in a 1000 mg pen for cellular-energy and longevity research.
Part of our Metabolic & Weight.
related stacksbundle & save
Advanced Lean Stack
Triple-agonist fat loss, cellular energy and visceral-fat support, the full lean protocol.
Retatrutide 40
NAD+ 1000
Tesamorelin 20
bundle & save
Metabolic Reset
Mitochondrial support underneath a dual-agonist protocol.
MOTS-C + SS-31 40
Tirzepatide 40
bundle & save
Advanced Metabolic Reset
The triple agonist, mitochondrial blend and NAD+, the deepest reset in the range.
MOTS-C + SS-31 40
Retatrutide 40
NAD+ 1000
Overview
This page sets out what the Lean Stack Research Bundle contains, what the 15% saving applies to, and what the evidence covers for each compound.
Add the Lean Stack Research Bundle to your order and confirm current ZAR pricing at checkout →
Veyvora’s Lean Stack Research Bundle is a defined two-pen research stack pairing Tirzepatide 40 and NAD+ 1000, listed under the Metabolic & Weight category as a “bundle & save” offer with a stated 15% saving versus buying each pen separately, as of 30 August 2026 [2]. Exact ZAR pricing and real-time stock status are confirmed at checkout [2]. Both pens are supplied for in-vitro laboratory research.
Key Takeaways
- The bundle pairs Tirzepatide 40 (dual GIP/GLP-1 receptor agonist, 40 mg click pen) with NAD+ 1000 (1,000 mg, 3 mL cellular-energy pen) at a stated 15% saving versus separate purchase, as of 30 August 2026.
- Component-level evidence covers each compound under its own study conditions; the paired protocol is the laboratory’s own research question.
- Both pens are supplied for in-vitro laboratory research; not for human or veterinary use.
- ZAR unit pricing, shipping charges and real-time stock status are confirmed at the product detail or checkout stage.
Exact Bundle Identity
Veyvora’s Lean Stack Research Bundle pairs Tirzepatide 40, a dual GIP (glucose-dependent insulinotropic polypeptide) / GLP-1 (glucagon-like peptide-1) receptor agonist in a 40 mg click pen, with NAD+ (nicotinamide adenine dinucleotide) 1000 (a 1,000 mg, 3 mL cellular-energy pen), sold together under the Lean Stack label at a stated 15% saving versus purchasing each pen separately, as of 30 August 2026 [2].
The bundle appears in Veyvora’s Metabolic & Weight category under “bundle & save” and carries the positioning description “Dual-agonist weight management with cellular energy underneath,” which describes the compounds’ receptor targets [2]. Exact ZAR pricing and real-time stock status are confirmed at checkout [2].
The Lean Stack is distinct from two sibling stacks listed on the same page: Advanced Lean Stack (Retatrutide 40 + NAD+ 1000 + Tesamorelin 20, 12% saving) and Metabolic Reset (MOTS-C + SS-31 40 + Tirzepatide 40, 15% saving) [2]. Substituting any sibling stack changes both the compound profile and the bundle identity, so researchers should confirm the exact pen names before ordering.
Before first use, researchers can verify a batch CoA against your pen to confirm that the pen in hand matches the identity and HPLC (high-performance liquid chromatography) purity data on the certificate.
Included Components
The Lean Stack Research Bundle contains two pens: Tirzepatide 40, a dual GIP/GLP-1 receptor agonist in a 40 mg click pen, and the NAD+ 1000 research pen, a 1,000 mg, 3 mL cellular-energy pen [1][2]. Both are supplied for in-vitro laboratory research use only.
| Component | Receptor target / mechanism | Nominal strength | Format | Product link |
|---|---|---|---|---|
| Tirzepatide 40 | Dual GIP/GLP-1 receptor agonist | 40 mg | Click pen | Confirm at checkout [2] |
| NAD+ 1000 | Cellular-energy / NAD+ repletion research | 1,000 mg | 3 mL click pen | Confirm at checkout [1] |
ZAR unit prices for each pen are confirmed at the product detail or checkout stage [1][2]. Per-click dosing specifications for each pen, including whether the 133 micrograms-per-click, 300-click specification applies to both components, are confirmed with the operator before ordering.
Individual-compound evidence exists for Tirzepatide 40 and NAD+ 1000 separately [1][2]. Researchers comparing receptor coverage across compounds may find the retatrutide versus tirzepatide comparison useful before finalising a bundle selection. For post-purchase handling, storage and stability guidance covers the conditions applicable to this pen format.
State of the Evidence
Veyvora’s pages present mechanistic descriptions and research context for Tirzepatide 40 as a dual GIP/GLP-1 receptor agonist and for NAD+ 1000 as a cellular-energy research compound [1][2]. The Lean Stack label “Dual-agonist weight management with cellular energy underneath” describes the two receptor targets [1].
Published mechanistic data for each compound, sourced from peer-reviewed literature, applies to that compound under the conditions of the study in which researchers generated it [1][2]. The interaction between GIP/GLP-1 agonism and NAD+ repletion pathways is an open question in the literature, which is what makes the paired format a research tool: combining the two in a laboratory protocol is the experiment.
Researchers weighing receptor coverage across related compounds may find the MOTS-c versus SS-31 comparison useful for understanding the mitochondrial-peptide evidence separately from the Lean Stack purchase decision. Those comparing other formats can review Veyvora’s research-peptide catalogue for alternative compound selections.
Batch Documents and Handling
Every pen in the Lean Stack Research Bundle ships with a batch-specific certificate of analysis (CoA) tied to its batch number, covering compound identity and HPLC purity [2]. Veyvora states that each pen in the Metabolic & Weight range undergoes independent assay before dispatch, so that assay results are tied to the specific batch rather than a generic product specification [2]. Researchers can verify a batch CoA against their pen before first use to confirm the batch number matches the supplied documentation.
For a precise account of how HPLC purity data is measured and reported, see what HPLC purity does and does not prove [2].
Shipping temperature, insulated packaging specification and storage conditions for the Lean Stack bundle are stated in the product detail or dispatch documentation; confirm them there before purchase [2].
Commercial Terms
Veyvora lists the Lean Stack Research Bundle with a stated 15% saving compared with purchasing Tirzepatide 40 and NAD+ 1000 individually, as of 30 August 2026 [1][2]. The bundle appears under the “bundle & save” label on the Metabolic & Weight category page, confirming active availability at that date [1].
Confirm ZAR unit pricing, shipping charges, dispatch timeframes and real-time stock status directly from the product detail or checkout page before ordering [1][2]. Minimum order quantities, wholesale tiers and distributor-specific pricing are available from Veyvora on request [1][2].
For post-purchase handling requirements, including temperature and storage conditions, see storage and stability guidance. Researchers weighing Tirzepatide 40 against alternative receptor-coverage profiles can consult the retatrutide versus tirzepatide comparison before finalising their bundle selection.
Confirm current ZAR pricing and stock status for the Lean Stack Research Bundle at checkout →
Research Use
Every pen in the Lean Stack Research Bundle, Tirzepatide 40 and NAD+ 1000, is supplied for in-vitro laboratory research, such as receptor-binding and signalling assays, cellular-energy assays in cell culture and use as analytical reference material [2]. Not for human or veterinary use; the Metabolic Reset stack page states that each pen is “supplied for laboratory research use only, not for human or veterinary use” [1][2].
Receptor-target language on the product pages describes biochemical mechanism [1][2]. The batch-specific CoA supplied with each pen reports compound identity and HPLC purity for the lot [1][2].
Researchers evaluating mitochondrial peptides such as MOTS-C and SS-31 outside the Lean Stack scope can consult the MOTS-c versus SS-31 comparison for mechanism-level differentiation. To review the full range of available research compounds, including Retatrutide 40, Tesamorelin 20, and others in the Metabolic & Weight category, visit Veyvora’s research-peptide catalogue and confirm current pricing, stock status, and batch availability directly on the product detail page before placing an order.
Sources
[1] Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight, pubmed.ncbi.nlm.nih.gov, https://pubmed.ncbi.nlm.nih.gov/39996356/ [2] the range, research peptides | Veyvora, veyvora.com, https://veyvora.com/categories/metabolic
